In stock
Arc Research
Three receptors. One breakthrough compound. Retatrutide simultaneously activates GLP-1, GIP, and glucagon pathways — delivering unmatched metabolic control. A superior advancement over semaglutide and tirzepatide.
Couldn't load pickup availability
